Low dose oral minoxidil in alopecia areata

Comparison of the Effectiveness of adding low-dose oral minoxidil in the treatment of patients with alopecia areata treated with Janus kinase inhibitor compared to placebo in Razi Hospital patients, 1403-1404.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240512061760N1

Enrollment

Registered

2024-10-27

Start date

2024-09-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia Areata. Alopecia areata

Interventions

Intervention 1: Intervention group: Low dose Oral minoxidil(2.5mg per day) with JAK inhibitor during 6 month, both daily. Intervention 2: Control group: Placebo with JAK inhibitor during 6 month, both

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: SALT Score More than 20 Age above 18 Age below 50 Compliance to systemic treatment

Exclusion criteria

Exclusion criteria: Pregnancy Lactation History of cardiovascular disease History of Hypertension Active infectious disease Malignancy History of DVT

Design outcomes

Primary

Measure	Time frame
SALT Score. Timepoint: Every 2 month until 6 month, from start of study. Method of measurement: Physical examination.	—

Secondary

Measure	Time frame
Quality of Life. Timepoint: First visit and the last one(6 month after). Method of measurement: DLQI(Dermatology Life Quality Index) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepehr Boroumand Sani

Tehran University of Medical Sciences

sbsani1996@gmail.com+98 21 5288 8282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026